Golimumab Completed Phase 4 Trials for Spondylarthropathy Treatment

Indications	Status	Purpose	Phase
DBCOND0034564 (Spondylarthropathy)	Completed	Treatment	4

clinicaltrials.gov Identifier	Title	Drugs
NCT01604629	Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF	Adalimumab (DB00051) Etanercept (DB00005) Golimumab (DB06674) Infliximab (DB00065)